Time discrimination: a comparison between healthy controls, unmedicated schizophrenics, zotepine-treated schizophrenics and schizophrenics treated with conventional neuroleptics

被引:0
|
作者
Ulferts, J [1 ]
Meyer-Lindenberg, A [1 ]
Gallhofer, B [1 ]
机构
[1] Univ Giessen, Zentrum Psychiat, D-35385 Giessen, Germany
关键词
zotepine; schizophrenia; time discrimination;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
In a cross-sectional study time discrimination performance was examined of healthy controls, unmedicated schizophrenics, zotepine-treated schizophrenics, and schizophrenics treated with conventional neuroleptics (haloperidol, fluphenacine). There were no significant differences among the groups in age and gender, the schizophrenic groups were not significantly different in BPRS-score and cumulative length of stay. The medication of the patients treated with neuroleptics was given in equipotent doses. Statistics was performed by ANOVA and subsequent Least Significant Difference (LSD) Test. In relation to the healthy controls a significant impairment of time perception of unmedicated schizophrenic patients as well as conventionelly treated schizophrenic patients could be demonstrated, but not of patients treated with zotepine. Further, unmedicated and conventionally treated patients showed a significant impairment in time estimation compared to patients treated with zotepine. The study shows an illness-related impairment among schizophrenics with a positive effect of zotepine on time discrimination performance. The receptor binding profiles of the various drugs as likely cause of these differences are discussed.
引用
收藏
页码:133 / 138
页数:6
相关论文
共 28 条
  • [1] NEUROFIBRILLARY PATHOLOGY IN BRAINS OF ELDERLY SCHIZOPHRENICS TREATED WITH NEUROLEPTICS
    WISNIEWSKI, HM
    CONSTANTINIDIS, J
    WEGIEL, J
    BOBINSKI, M
    TARNAWSKI, M
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1994, 8 (04): : 211 - 227
  • [2] DEPRESSION, PARKINSONIAN SYMPTOMS, AND NEGATIVE SYMPTOMS IN SCHIZOPHRENICS TREATED WITH NEUROLEPTICS
    PROSSER, ES
    CSERNANSKY, JG
    KAPLAN, J
    THIEMANN, S
    BECKER, TJ
    HOLLISTER, LE
    [J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 1987, 175 (02) : 100 - 105
  • [3] Implicit and explicit learning in schizophrenics treated with olanzapine and with classic neuroleptics
    Andreas Stevens
    Jürgen Schwarz
    Benedikt Schwarz
    Ilona Ruf
    Thomas Kolter
    Joerg Czekalla
    [J]. Psychopharmacology, 2002, 160 : 299 - 306
  • [4] Implicit and explicit learning in schizophrenics treated with olanzapine and with classic neuroleptics
    Stevens, A
    Schwarz, J
    Schwarz, B
    Ruf, I
    Kolter, T
    Czekalla, J
    [J]. PSYCHOPHARMACOLOGY, 2002, 160 (03) : 299 - 306
  • [5] Positron emission tomography in schizophrenics treated with atypical and typical neuroleptics
    Buchsbaum, M
    Hazlett, E
    Bark, N
    Gupta, A
    Fallon, J
    Guich, S
    Haznedar, M
    [J]. SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 163 - 163
  • [6] Short-term cognitive improvement in schizophrenics treated with typical and atypical neuroleptics
    Rollnik, JD
    Borsutzky, M
    Huber, TJ
    Mogk, H
    Seifert, J
    Emrich, HM
    Schneider, U
    [J]. NEUROPSYCHOBIOLOGY, 2002, 45 (02) : 74 - 80
  • [7] CSF HVA/5HIAA ratio is normally distributed in unmedicated and clozapine treated schizophrenics as compared with normal controls
    Risch, SC
    Molloy, M
    Batchelor, M
    Speer, A
    Lewine, RRJ
    DeVane, CL
    George, M
    [J]. SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 67 - 67
  • [8] Early developmental differences between DSM-III-R schizophrenics treated with clozapine and typical neuroleptics
    Makikyro, T
    Leinonen, E
    Koponen, H
    Jarvelin, MR
    Hakko, H
    Saarnisaari, O
    Isohanni, M
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 1998, 32 (02) : 105 - 110
  • [9] COMPARISON OF 3,4-DIMETHOXYPHENYLETHYLAMINE TREATED PLASMA FROM CHRONIC-SCHIZOPHRENICS AND CONTROLS
    BERGEN, JR
    MULHALL, S
    MOORMAN, P
    [J]. RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1975, 10 (02): : 331 - 335
  • [10] Medial prefrontal H-1 MRS findings in never-treated schizophrenics and healthy controls
    Williamson, PC
    Bartha, R
    Drost, DJ
    Malla, A
    Carr, TJ
    Cortese, L
    MacFabe, GC
    Rylett, RJ
    Neufeld, WRJ
    [J]. SCHIZOPHRENIA RESEARCH, 1997, 24 (1-2) : 182 - 182